Technical Analysis for MDXH - MDxHealth SA

Grade Last Price % Change Price Change
F 2.08 2.46% 0.05
MDXH closed up 2.46 percent on Friday, November 1, 2024, on 32 percent of normal volume.
Earnings due: Nov 6
*** please verify all earnings dates ***
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Up

Date Alert Name Type % Chg
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Bollinger Band Squeeze Range Contraction 0.00%
Upper Bollinger Band Walk Strength 0.00%
Inside Day Range Contraction 0.00%
Gapped Up Strength 0.00%
Bollinger Band Squeeze Range Contraction 2.46%
BB Squeeze + Upper Band Touch Range Contraction 2.46%
Gapped Up Strength 2.46%
Upper Bollinger Band Touch Strength 2.46%
20 DMA Support Bullish 1.96%

   Recent Intraday Alerts

Alert Time
Gap Up Partially Closed about 19 hours ago
Rose Above Upper Bollinger Band about 19 hours ago
Up 2% about 19 hours ago
Upper Bollinger Band Resistance about 19 hours ago
Gapped Up (Partial) about 22 hours ago

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

MDxHealth SA Description

MDxHealth SA operates as a molecular diagnostics company in Belgium, the Netherlands, Spain, Poland, Italy, the United States, rest of European Union, and internationally. The company develops and commercializes epigenetic and other molecular tests for cancer assessment and the personalized treatment of patients. Its tests are based on proprietary genetic, epigenetic, and other molecular technologies, as well as assist physicians with the diagnosis of urologic cancers, prognosis of recurrence risk, and prediction of response to a specific therapy. The company's product pipeline includes tests for bladder, kidney, and other urologic cancers. Its products include ConfirmMDx, a tissue test for prostate cancer; and SelectMDx, a non-invasive urine test for prostate cancer. The company was formerly known as OncoMethylome Sciences SA and changed its name to MDxHealth SA in October 2010. MDxHealth SA was incorporated in 2003 and is headquartered in Herstal, Belgium.


Classification

Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Medicine Biotechnology Cancer Clinical Medicine Prostate Cancer Medical Genetics Urology Molecular Diagnostics Molecular Technologies

Is MDXH a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 42.256
52 Week Low 1.95
Average Volume 95,951
200-Day Moving Average 2.78
50-Day Moving Average 2.35
20-Day Moving Average 2.02
10-Day Moving Average 2.04
Average True Range 0.10
RSI (14) 45.36
ADX 25.7
+DI 26.95
-DI 17.04
Chandelier Exit (Long, 3 ATRs) 1.96
Chandelier Exit (Short, 3 ATRs) 2.24
Upper Bollinger Bands 2.08
Lower Bollinger Band 1.96
Percent B (%b) 0.97
BandWidth 6.05
MACD Line -0.07
MACD Signal Line -0.10
MACD Histogram 0.0312
Fundamentals Value
Market Cap 56.76 Million
Num Shares 27.3 Million
EPS -2.10
Price-to-Earnings (P/E) Ratio -0.99
Price-to-Sales 1.69
Price-to-Book 5.41
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 2.16
Resistance 3 (R3) 2.15 2.11 2.14
Resistance 2 (R2) 2.11 2.09 2.12 2.14
Resistance 1 (R1) 2.10 2.08 2.11 2.11 2.13
Pivot Point 2.06 2.06 2.07 2.07 2.06
Support 1 (S1) 2.05 2.04 2.06 2.06 2.03
Support 2 (S2) 2.01 2.03 2.02 2.02
Support 3 (S3) 2.00 2.01 2.02
Support 4 (S4) 2.01